Ideal Area for Unprotected Left Main PCI

Courtesy of Dr. Carlos Fava. 

Unprotected left main PCI (PCI-UPLMS) is an acceptable and comparable strategy vs CABG, although the use of IVUS is advisable, since it has shown better evolution and mortality. However, the adequate stent expansion remains unclear. 

angioplastia primaria estrategia farmacoinvasiva

Researchers carried out a sub-analyzis of the NOBLE trial. Of the total 603 patients receiving PCI UPLM, IVUS was used in 474, pre-PCI in 270 (45%) and post-PCI in 435 (72%).

At 5 years, MACE rate was 18.9% if post-PCI IVUS was performed versus 25.0% if it was not performed (p=0.45). However, target vessel revascularization was lower with post PCI IVUS (5.1% vs 11.6% p=0.001). 

To study stent expansion at left main level, minimal stent area (MSA) was slit into 3 tertiles (4.4-10.8 mm2, 10.9-13.4 mm2 and 13.4-25.4 mm2).

Patients in the last tertile presented lower target vessel revascularization (TLR) compared to those in the first tertile (12.2% vs 0% p=0.002) and lower need for repeat revascularization (17.6% vs. 5.2% p=0.02).  


Read also: Quantitative Angiography that Estimates Shear Stress and Predicts Events.


There were no differences in death, MI or stent thrombosis.

Conclusion

Post PCI IVUS assessment and adequate stent expansion was not associated to reduced MACE rate, yet there was a reduction in unprotected left main TLR.

The use of IVUS to prevent stent underexpansion in unprotected left main PCI might improve evolution. 

Courtesy of Dr. Carlos Fava. 

Original Title: Intrvascular ultrasound to guide left main stem intervention: a NOBLE trial substudy.

Reference: Andrew Ladwiniec, et al. EuroIntervention 2020;16:201-209.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...